1. Home
  2. TRDA vs SRI Comparison

TRDA vs SRI Comparison

Compare TRDA & SRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRDA
  • SRI
  • Stock Information
  • Founded
  • TRDA 2016
  • SRI 1965
  • Country
  • TRDA United States
  • SRI United States
  • Employees
  • TRDA N/A
  • SRI N/A
  • Industry
  • TRDA Biotechnology: Pharmaceutical Preparations
  • SRI Auto Parts:O.E.M.
  • Sector
  • TRDA Health Care
  • SRI Consumer Discretionary
  • Exchange
  • TRDA Nasdaq
  • SRI Nasdaq
  • Market Cap
  • TRDA 222.5M
  • SRI 210.9M
  • IPO Year
  • TRDA 2021
  • SRI 1997
  • Fundamental
  • Price
  • TRDA $5.84
  • SRI $6.61
  • Analyst Decision
  • TRDA Strong Buy
  • SRI Buy
  • Analyst Count
  • TRDA 3
  • SRI 1
  • Target Price
  • TRDA $25.67
  • SRI $16.00
  • AVG Volume (30 Days)
  • TRDA 350.3K
  • SRI 178.9K
  • Earning Date
  • TRDA 11-04-2025
  • SRI 10-29-2025
  • Dividend Yield
  • TRDA N/A
  • SRI N/A
  • EPS Growth
  • TRDA N/A
  • SRI N/A
  • EPS
  • TRDA N/A
  • SRI N/A
  • Revenue
  • TRDA $79,476,000.00
  • SRI $877,921,000.00
  • Revenue This Year
  • TRDA N/A
  • SRI N/A
  • Revenue Next Year
  • TRDA N/A
  • SRI $7.68
  • P/E Ratio
  • TRDA N/A
  • SRI N/A
  • Revenue Growth
  • TRDA N/A
  • SRI N/A
  • 52 Week Low
  • TRDA $4.93
  • SRI $3.54
  • 52 Week High
  • TRDA $21.79
  • SRI $10.33
  • Technical
  • Relative Strength Index (RSI)
  • TRDA 51.80
  • SRI 33.52
  • Support Level
  • TRDA $5.82
  • SRI $6.24
  • Resistance Level
  • TRDA $6.90
  • SRI $7.72
  • Average True Range (ATR)
  • TRDA 0.36
  • SRI 0.29
  • MACD
  • TRDA 0.07
  • SRI -0.14
  • Stochastic Oscillator
  • TRDA 45.88
  • SRI 20.94

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

About SRI Stoneridge Inc.

Stoneridge Inc is a manufacturer of electrical and electronic components used in automotive vehicles. The company produces instrumentation systems, vehicle management electronics, application-specific switches and actuators, sensors, security alarms, and vehicle tracking devices and monitoring services for commercial, automotive, off-highway, and agricultural vehicle markets. The company has three reportable segments: Control Devices, Electronics, and Stoneridge Brazil. It generates the majority of its revenue from the Electronics segment that produces driver information systems, camera-based vision systems, connectivity, and compliance products, and electronic control units. Its geographic segments include America, South America, Europe and Other.

Share on Social Networks: